Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years

I. Peregrin-Alvarez, M. N. Akl, C. P. Morrow, J. F. Magrina

Research output: Contribution to journalArticle

Abstract

Purpose of investigation: Recurrent metastatic adenocarcinoma of the cervix is associated with an extremely poor prognosis. Treatment options for recurrent disease are limited and cure is extremely rare. Case report: We report a case of a 43-year-old patient with Stage IB adenocarcinoma of the cervix. She had multiple metastatic recurrence episodes salvaged with several radical surgeries, external and intraoperative irradiation, and chemotherapy over a survival period of 16 years. Conclusion: We conclude that long-term multi-modal salvage treatment may achieve longer survival in rare cases with recurrent metastatic adenocarcinoma of the cervix.

Original languageEnglish (US)
Pages (from-to)333-335
Number of pages3
JournalEuropean Journal of Gynaecological Oncology
Volume31
Issue number3
StatePublished - 2010

Keywords

  • Long-term survival
  • Metastatic adenocarcinoma
  • Recurrent adenocarcinoma

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years'. Together they form a unique fingerprint.

  • Cite this

    Peregrin-Alvarez, I., Akl, M. N., Morrow, C. P., & Magrina, J. F. (2010). Metastatic and recurrent adenocarcinoma of the uterine cervix: A long-term survival of 16 years. European Journal of Gynaecological Oncology, 31(3), 333-335.